Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.

被引：0
|
作者：
Moon, Helen H. [1 ]
Kearney, Mairead [2 ]
Mahmoudpour, Seyed Hamidreza [2 ]
Ike, Chiemeka [3 ]
Morris, Valerie A. [3 ]
Rava, Andrew [4 ]
Kim, Sonia [5 ]
Sun, Haiyan [5 ]
Boyd, Marley [5 ]
Rey, Gabriel Gomez [5 ]
机构：
[1] Kaiser Permanente, Riverside, CA USA
[2] Healthcare Business Merck KGaA, Darmstadt, Germany
[3] EMD Serono, Rockland, MA USA
[4] Genesis Res, Hoboken, NJ USA
[5] Genesis Res LLC, Hoboken, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-12268; 130-544; 261-492-9019; 298-145-222-9001; 261-492-3532-2370-7650-2700; 261-566-9263; 6; 4; 3; 2; 1880; 1876; 3224; 295; 12; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [21] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Avenue: A prospective observational study of real-world treatment patterns and treatment outcomes in patients with advanced or metastatic urothelial carcinoma treated with avelumab first-line maintenance therapy
    Gschwend, J.
    Belz, H.
    Boegemann, M.
    Niegisch, G.
    Janssen, J.
    Henrici, M.
    Schostak, M.
    Gruenwald, V
    Wille, K.
    Wunderlich, H.
    Schlack, K.
    Stark, L.
    Mundel, T.
    Grimm, M. O.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 266 - 266
  • [23] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [24] Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
    Park, Se Hoon
    Shin, Sang Joon
    Rha, Sun Young
    Beom, Seung-Hoon
    Seo, Ho Kyung
    Keam, Bhumsuk
    Kim, Miso
    Hong, Yoon-Hee
    Yoon, Shinkyo
    Lee, Jae-Lyun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Real-world (rw) treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC): Insights from The US Oncology Network electronic health record (EHR)
    Bupathi, Manojkumar
    Sura, Sneha
    Ike, Chiemeka
    Morris, Valerie A.
    Conkling, Paul R.
    Todoroff, Karen
    Bhanegaonkar, Abhijeet
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] PATRIOT II: An ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States.
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen
    Hutson, Thomas E.
    Gupta, Shilpa
    Sternberg, Cora N.
    Pickard, A. Simon
    Dave, Vaidehi
    Han, Natalia
    Shillington, Alicia C.
    Devgan, Geeta
    Kim, Ruth
    Thakkar, Sheena
    Katzenstein, Howard
    Bhanegaonkar, Abhijeet
    Liu, Frank
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [27] REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Alicia, K. Morgans
    Guru, P. Sonpavde
    Vanessa, Shih
    Phoebe, Wright
    Zsolt, Hepp
    Candice, L. Willmon
    Nancy, Chang
    Steven, Sesterhenn
    Boppudi, Naga Sai Sriteja
    Thomas, Powles
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S26 - S27
  • [28] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
  • [29] Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen H.
    Gupta, Shilpa
    Hutson, Thomas E.
    Sternberg, Cora N.
    Brown, Jason
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie A.
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 697 - 697
  • [30] Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia
    Moujaber, Tania
    Tran Ben
    Liow, Elizabeth
    Clay, Timothy
    Bennett, Geer
    Kearney, Mairead
    Gibberd, Alison
    Gurney, Howard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 94 - 95
12345